Clinical strategies for treating metastatic castration-sensitive ...
Dec 16, 2025 · A recent Urology Times Clinical Forum in Chicago, moderated by Aaron Berger, MD, chief medical officer and director of Clinical Research for Associated Urological Specialists in Illinois, …
Systemic Therapy in Patients With Metastatic Castration-Resistant ...
May 2, 2025 · What are the treatment options for patients previously treated with ADT alone in castration-sensitive or nonmetastatic castration-resistant prostate cancer (CRPC) setting and whose …
The Management of Metastatic Castrate-Sensitive Prostate Cancer: …
This commentary highlights 2 international studies on real-world treatment trends and patterns among patients with metastatic castration-sensitive and resistant prostate cancer and how interventions …
Metastatic Castration-Resistant Prostate Cancer Facts
Apr 18, 2025 · Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options and prognosis.
Treatment for Metastatic Prostate Cancer Often Suboptimal
Feb 18, 2025 · In most people with metastatic hormone-sensitive prostate cancer, the cancer eventually changes so that it can grow without being reliant on testosterone from the testes, known as hormone …
FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer
Dec 12, 2025 · FDA approved niraparib, abiraterone acetate, and prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer, showing significant rPFS improvement in the …
Akeega Approved for BRCA2-Mutated Metastatic Castration-Sensitive ...
Dec 16, 2025 · The FDA has approved Akeega plus prednisone for adults with deleterious BRCA2-mutated metastatic castration-sensitive prostate cancer.
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic ...
Dec 15, 2025 · FDA approves niraparib plus abiraterone and prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer based on AMPLITUDE trial data.
Treatments for metastatic castration-sensitive prostate cancer
Metastatic castration-sensitive prostate cancer (CSPC) can be treated with hormone therapy, radiation therapy and chemotherapy.
How We Treat Metastatic Castration-Sensitive Prostate Cancer
Aug 16, 2024 · Risk Stratifying Metastatic Castration-Sensitive Prostate Cancer Among the numerous available strategies, the best choice of first-line therapy for mCSPC is a contentious matter, primarily …